Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers
Abstract Development of low‐clearance (CL) compounds that are slowly metabolized is a major goal in the pharmaceutical industry. However, the pursuit of low intrinsic CL (CLint) often leads to significant challenges in evaluating the pharmacokinetics of such compounds. Although in vitro-in vivo extr...
Saved in:
Main Authors: | Kosuke Yoshida (Author), Yuki Doi (Author), Norihiko Iwazaki (Author), Hidenori Yasuhara (Author), Yuka Ikenaga (Author), Hidetoshi Shimizu (Author), Tomohisa Nakada (Author), Tomoko Watanabe (Author), Chise Tateno (Author), Seigo Sanoh (Author), Yaichiro Kotake (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?
by: Dion Brocks, et al.
Published: (2022) -
Clearance Concepts: Fundamentals and Application to Pharmacokinetic Behavior of Drugs
by: Reza Mehvar
Published: (2018) -
Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling
by: Cindy H. T. Yeung, et al.
Published: (2023) -
Erratum to 'Piecing Together Human Adult Comparative Pharmacokinetic Trials and Rodent Studies: What Happens to Drug Clearance in Obesity?'
by: Dion Brocks
Published: (2022) -
Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
by: Yang Chu, et al.
Published: (2020)